|
1
|
Ostrom QT, Bauchet L, Davis FG, Deltour I,
Fisher JL, Langer CE, Pekmezci M, Schwartzbaum JA, Turner MC, Walsh
KM, et al: The epidemiology of glioma in adults: A ‘state of the
science’ review. Neuro Oncol. 16:896–913. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Molinaro AM, Taylor JW, Wiencke JK and
Wrensch MR: Genetic and molecular epidemiology of adult diffuse
glioma. Nat Rev Neurol. 15:405–417. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Cancer Genome Atlas Research Network, .
Brat DJ, Verhaak RG, Aldape KD, Yung WK, Salama SR, Cooper LA,
Rheinbay E, Miller CR, Vitucci M, et al: Comprehensive, integrative
genomic analysis of diffuse lower-grade gliomas. N Engl J Med.
372:2481–2498. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Louis DN, Ohgaki H, Wiestler OD, Cavenee
WK, Burger PC, Jouvet A, Scheithauer BW and Kleihues P: The 2007
WHO classification of tumours of the central nervous system. Acta
Neuropathol. 114:97–109. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Yuan B, Wang G, Tang X, Tong A and Zhou L:
Immunotherapy of glioblastoma: Recent advances and future
prospects. Hum Vaccin Immunother. 18:20554172022. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Stupp R, Mason WP, van den Bent MJ, Weller
M, Fisher B, Taphoorn MJ, Belanger K, Brandes AA, Marosi C, Bogdahn
U, et al: Radiotherapy plus concomitant and adjuvant temozolomide
for glioblastoma. N Engl J Med. 352:987–996. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Roukens MG, Alloul-Ramdhani M, Moghadasi
S, Op den Brouw M and Baker DA: Downregulation of vertebrate Tel
(ETV6) and Drosophila Yan is facilitated by an evolutionarily
conserved mechanism of F-box-mediated ubiquitination. Mol Cell
Biol. 28:4394–4406. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Bonacci T and Emanuele MJ: Dissenting
degradation: Deubiquitinases in cell cycle and cancer. Semin Cancer
Biol. 67:145–158. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Abbas R and Larisch S: Killing by
degradation: Regulation of apoptosis by the
ubiquitin-proteasome-system. Cells. 10:34652021. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Daulny A and Tansey WP: Damage control:
DNA repair, transcription, and the ubiquitin-proteasome system. DNA
Repair (Amst). 8:444–448. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Bendotti C, Marino M, Cheroni C, Fontana
E, Crippa V, Poletti A and De Biasi S: Dysfunction of constitutive
and inducible ubiquitin-proteasome system in amyotrophic lateral
sclerosis: Implication for protein aggregation and immune response.
Prog Neurobiol. 97:101–126. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Han D, Wang L, Jiang S and Yang Q: The
ubiquitin-proteasome system in breast cancer. Trends Mol Med.
29:599–621. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Reinstein E and Ciechanover A: Narrative
review: Protein degradation and human diseases: The ubiquitin
connection. Ann Intern Med. 145:676–684. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Dang F, Nie L and Wei W: Ubiquitin
signaling in cell cycle control and tumorigenesis. Cell Death
Differ. 28:427–438. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Ciechanover A: The unravelling of the
ubiquitin system. Nat Rev Mol Cell Biol. 16:322–324. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Chan CH, Li CF, Yang WL, Gao Y, Lee SW,
Feng Z, Huang HY, Tsai KK, Flores LG, Shao Y, et al: The Skp2-SCF
E3 ligase regulates Akt ubiquitination, glycolysis, herceptin
sensitivity, and tumorigenesis. Cell. 149:1098–1111. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Meng X, Liu X, Guo X, Jiang S, Chen T, Hu
Z, Liu H, Bai Y, Xue M, Hu R, et al: FBXO38 mediates PD-1
ubiquitination and regulates anti-tumour immunity of T cells.
Nature. 564:130–135. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Wang Z, Liu P, Inuzuka H and Wei W: Roles
of F-box proteins in cancer. Nat Rev Cancer. 14:233–247. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Wu J, Zhang X, Zhang L, Wu CY, Rezaeian
AH, Chan CH, Li JM, Wang J, Gao Y, Han F, et al: Skp2 E3 ligase
integrates ATM activation and homologous recombination repair by
ubiquitinating NBS1. Mol Cell. 46:351–361. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Nelson DE, Randle SJ and Laman H: Beyond
ubiquitination: The atypical functions of Fbxo7 and other F-box
proteins. Open Biol. 3:1301312013. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Chen D, Liu X, Xia T, Tekcham DS, Wang W,
Chen H, Li T, Lu C, Ning Z, Liu X, et al: A multidimensional
characterization of E3 ubiquitin ligase and substrate interaction
network. iScience. 16:177–191. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Li Y, Cui K, Zhang Q, Li X, Lin X, Tang Y,
Prochownik EV and Li Y: FBXL6 degrades phosphorylated p53 to
promote tumor growth. Cell Death Differ. 28:2112–2125. 2021.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Yu Y, Yao W, Wang T, Xue W, Meng Y, Cai L,
Jian W, Yu Y and Zhang C: FBXL6 depletion restrains clear cell
renal cell carcinoma progression. Transl Oncol. 26:1015502022.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Shi W, Feng L, Dong S, Ning Z, Hua Y, Liu
L, Chen Z and Meng Z: FBXL6 governs c-MYC to promote hepatocellular
carcinoma through ubiquitination and stabilization of HSP90AA1.
Cell Commun Signal. 18:1002020. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Schiff D: Low-grade gliomas. Continuum
(Minneap Minn). 23:1564–1579. 2017.PubMed/NCBI
|
|
26
|
Russell B, Collins A, Dally M, Dowling A,
Gold M, Murphy M and Philip J: Living longer with adult high-grade
glioma: Setting a research agenda for patients and their
caregivers. J Neurooncol. 120:1–10. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Ding H, Zhao J, Zhang Y, Yu J, Liu M, Li
X, Xu L, Lin M, Liu C, He Z, et al: Systematic analysis of drug
vulnerabilities conferred by tumor suppressor loss. Cell Rep.
27:3331–3344.e6. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Dai Z, Wu J, Chen F, Cheng Q, Zhang M,
Wang Y, Guo Y and Song T: CXCL5 promotes the proliferation and
migration of glioma cells in autocrine- and paracrine-dependent
manners. Oncol Rep. 36:3303–3310. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Zhang J, Lin XT, Yu HQ, Fang L, Wu D, Luo
YD, Zhang YJ and Xie CM: Elevated FBXL6 expression in hepatocytes
activates VRK2-transketolase-ROS-mTOR-mediated immune evasion and
liver cancer metastasis in mice. Exp Mol Med. 55:2162–2176. 2023.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Wu W, Klockow JL, Zhang M, Lafortune F,
Chang E, Jin L, Wu Y and Daldrup-Link HE: Glioblastoma multiforme
(GBM): An overview of current therapies and mechanisms of
resistance. Pharmacol Res. 171:1057802021. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Chinot OL, Wick W, Mason W, Henriksson R,
Saran F, Nishikawa R, Carpentier AF, Hoang-Xuan K, Kavan P, Cernea
D, et al: Bevacizumab plus radiotherapy-temozolomide for newly
diagnosed glioblastoma. N Engl J Med. 370:709–722. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Chen J, McKay RM and Parada LF: Malignant
glioma: Lessons from genomics, mouse models, and stem cells. Cell.
149:36–47. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Liu LY, Ji MS, Nguyen NT, Chow FE, Molaie
DM, Pianka ST, Green RM, Liau LM, Ellingson BM, Nghiemphu PL, et
al: Patterns of long-term survivorship following bevacizumab
treatment for recurrent glioma: A case series. CNS Oncol.
8:CNS352019. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Ghorbani A, Avery LM, Sohaei D,
Soosaipillai A, Richer M, Horbinski C, McCortney K, Xu W, Diamandis
EP and Prassas I: Discovery of novel glioma serum biomarkers by
proximity extension assay. Clin Proteomics. 20:122023. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Cheng J, Guo J, Wang Z, North BJ, Tao K,
Dai X and Wei W: Functional analysis of Cullin 3 E3 ligases in
tumorigenesis. Biochim Biophys Acta Rev Cancer. 1869:11–28. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Naseem Y, Zhang C, Zhou X, Dong J, Xie J,
Zhang H, Agboyibor C, Bi Y and Liu H: Inhibitors targeting the
F-BOX proteins. Cell Biochem Biophys. 81:577–597. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
D'Angiolella V, Donato V, Vijayakumar S,
Saraf A, Florens L, Washburn MP, Dynlacht B and Pagano M:
SCF(Cyclin F) controls centrosome homeostasis and mitotic fidelity
through CP110 degradation. Nature. 466:138–142. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Rye MS, Wiertsema SP, Scaman ES, Oommen J,
Sun W, Francis RW, Ang W, Pennell CE, Burgner D, Richmond P, et al:
FBXO11, a regulator of the TGFβ pathway, is associated with severe
otitis media in Western Australian children. Genes Immun.
12:352–359. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Duan S, Cermak L, Pagan JK, Rossi M,
Martinengo C, di Celle PF, Chapuy B, Shipp M, Chiarle R and Pagano
M: FBXO11 targets BCL6 for degradation and is inactivated in
diffuse large B-cell lymphomas. Nature. 481:90–93. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Santra MK, Wajapeyee N and Green MR: F-box
protein FBXO31 mediates cyclin D1 degradation to induce G1 arrest
after DNA damage. Nature. 459:722–725. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Yoshida Y, Tokunaga F, Chiba T, Iwai K,
Tanaka K and Tai T: Fbs2 is a new member of the E3 ubiquitin ligase
family that recognizes sugar chains. J Biol Chem. 278:43877–43884.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Yoshida Y, Chiba T, Tokunaga F, Kawasaki
H, Iwai K, Suzuki T, Ito Y, Matsuoka K, Yoshida M, Tanaka K and Tai
T: E3 ubiquitin ligase that recognizes sugar chains. Nature.
418:438–442. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Frescas D and Pagano M: Deregulated
proteolysis by the F-box proteins SKP2 and beta-TrCP: Tipping the
scales of cancer. Nat Rev Cancer. 8:438–449. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Nakayama KI and Nakayama K: Regulation of
the cell cycle by SCF-type ubiquitin ligases. Semin Cell Dev Biol.
16:323–333. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Maser RS, Choudhury B, Campbell PJ, Feng
B, Wong KK, Protopopov A, O'Neil J, Gutierrez A, Ivanova E, Perna
I, et al: Chromosomally unstable mouse tumours have genomic
alterations similar to diverse human cancers. Nature. 447:966–971.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Menyhárt O and Győrffy B: Multi-omics
approaches in cancer research with applications in tumor subtyping,
prognosis, and diagnosis. Comput Struct Biotechnol J. 19:949–960.
2021. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Liu K, Zhang Q, Lan H, Wang L, Mou P, Shao
W, Liu D, Yang W, Lin Z, Lin Q and Ji T: GCN5 Potentiates glioma
proliferation and invasion via STAT3 and AKT signaling pathways.
Int J Mol Sci. 16:21897–21910. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Ouyang C, Mu J, Lu Q, Li J, Zhu H, Wang Q,
Zou MH and Xie Z: Autophagic degradation of KAT2A/GCN5 promotes
directional migration of vascular smooth muscle cells by reducing
TUBA/α-tubulin acetylation. Autophagy. 16:1753–1770. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Zhang S, Zhang H and Yu L: HMGA2 promotes
glioma invasion and poor prognosis via a long-range chromatin
interaction. Cancer Med. 7:3226–3239. 2018. View Article : Google Scholar : PubMed/NCBI
|
